Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Condition: Hepatitis CInterventions: Drug: Telaprevir + peginterferon alfa + ribavirin; Drug: peginterferon alfa + ribavirin; Drug: peginterferon alfa + ribavirinSponsor: Janssen-Cilag International NVAvailable - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials